Bibliometric analysis of treatment modalities in calcific aortic valve stenosis

Yang He1, Yue-Jiao Yang1, Zhao-Jun Wang1

  • 1Department of Cardiovascular Medicine, The Second Xiangya Hospital, Central South University, Changsha, Hunan, China.

PubMed
Abstract

Insights

Calcific aortic valve stenosis (CAVS) lacks effective drug treatments. Bibliometric analysis reveals key research trends and identifies future directions for CAVS therapies, focusing on diagnostics and novel drug development.

Area of Science:

  • Cardiovascular Medicine
  • Bibliometrics
  • Medical Research Trends

Background:

  • Calcific aortic valve stenosis (CAVS) is a prevalent cardiovascular disease with high mortality.
  • Current pharmacological treatments for CAVS are ineffective in halting or preventing disease progression.
  • There is a critical need for novel therapeutic strategies and improved understanding of CAVS pathogenesis.

Purpose of the Study:

  • To conduct a bibliometric and visualization analysis of global research on calcific aortic valve stenosis (CAVS).
  • To identify key research trends, prolific contributors, and emerging hotspots in CAVS research.
  • To provide insights into current and future therapeutic possibilities for CAVS.

Main Methods:

  • Utilized the Web of Science database to retrieve publications on aortic stenosis and related treatments.
  • Analyzed 787 articles published up to September 2024 using VOSviewer and CiteSpace software.
  • Identified prolific authors, countries, institutions, and journals contributing to CAVS research.

Main Results:

  • Canada and the United States lead in publication volume for CAVS research.
  • Harvard University, Laval University, and the University of California are leading institutions.
  • Top research hotspots include stenosis, calcification, and progression, with a focus on therapeutic approaches, pathogenesis, and diagnostics.

Conclusions:

  • While surgical and interventional treatments are standard, they are insufficient for all patients.
  • Future research priorities include enhancing diagnostics, developing innovative therapies, and discovering novel drugs for CAVS.
  • Continued research is essential to address the evolving challenges and unmet needs in CAVS management.

Related Concept Videos

Mitral Stenosis II: Clinical features and Diagnostic Tests01:23

Mitral Stenosis II: Clinical features and Diagnostic Tests

Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...